$1.9M Vivimed Losartan Drug Contamination Settlement, Did Your Blood Pressure Medication Qualify? Claim Before June 2

Vivimed Life Sciences Pvt Ltd and Strides Pharma Science Ltd agreed to pay $1,899,000 to settle a class action lawsuit alleging that certain batches of their Losartan blood pressure medication contained NMBA — a probable human carcinogen. If you paid out of pocket for a retail purchase of Vivimed Losartan under one of eight specific National Drug Codes (NDCs), you may claim a cash payment. The claim deadline is June 2, 2026.

Quick Facts

Field	Detail
Settlement Amount	$1,899,000
Claim Deadline	June 2, 2026
Who Qualifies	U.S. consumers who paid out of pocket for Vivimed Losartan under the 8 impacted NDCs
Payout Per Person	Up to $4.30 per 30-day supply; up to $43 total (higher with documentation)
Proof Required	No — for standard claims. Yes — for claims above $4.30 per 30-day supply
Settlement Status	Preliminarily approved; final hearing June 30, 2026
Administrator	Postlethwaite & Netterville
Official Website	sartanmedicationsettlement.com

Where Things Stand Right Now

• This settlement is part of the larger federal MDL case In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation, Case No. 1:19-md-02875-RBK-SAK, pending in the U.S. District Court for the District of New Jersey.
• The court granted preliminary approval, and the final fairness hearing is set for June 30, 2026 at 10:00 a.m. in Courtroom 3D, U.S. District Court, Camden, New Jersey.
• The deadline to file a claim, opt out, or object is June 2, 2026 — the same date for all three options.

What Happened With Vivimed Losartan?

Losartan is a widely prescribed medication that helps control high blood pressure and protect the kidneys. In May 2019, the FDA announced that Vivimed Life Sciences — a pharmaceutical manufacturer based in Chennai, India — had voluntarily recalled 19 lots of its Losartan Potassium Tablets in 25 mg, 50 mg, and 100 mg dosages.

The recall happened because lab testing detected NMBA (N-Nitroso-N-methyl-4-aminobutyric acid), a nitrosamine compound, in the active pharmaceutical ingredient used to make the tablets. The FDA classified NMBA as a probable human carcinogen — meaning it may cause cancer with long-term exposure. Vivimed’s Losartan was distributed in the U.S. through Heritage Pharmaceuticals Inc., based in East Brunswick, New Jersey.

Plaintiffs in the class action lawsuit alleged that Vivimed manufactured and sold contaminated Losartan tablets, causing consumers to pay for a medication that did not meet safety standards. Vivimed denies all wrongdoing but agreed to settle to avoid the costs and risks of continued litigation. This settlement resolves only the economic loss claims — meaning what consumers paid for contaminated pills — not personal injury claims tied to health effects.

Did Your Losartan Qualify? Here’s How to Check

This is the single most important question — and the answer comes down to your medication’s National Drug Code (NDC). Every prescription bottle in the U.S. has an NDC printed on the label. You qualify for this settlement only if your Vivimed Losartan matches one of the eight impacted NDC numbers listed by the court.

The eight qualifying NDC codes are:

• 23155-644-09
• 23155-644-10
• 23155-645-03
• 23155-645-09
• 23155-645-10
• 23155-646-03
• 23155-646-09
• 23155-646-10

To find your NDC: Check the label on your Losartan bottle or ask your pharmacy to pull your prescription history. Pharmacies keep detailed dispensing records and can confirm which manufacturer’s product you received and its NDC code.

You may qualify if all of the following apply to you:

• You are an individual living in the United States, its territories, or possessions.
• You paid any amount of money out of pocket for retail purchases of Vivimed Losartan finished drug formulations under one of the eight qualifying NDC codes listed above.
• Your purchase was not covered entirely through a third-party payor (like an insurance company) or a government program (like Medicare Part D or Medicaid).

Related article: Costco Auto-renewal Class Action Lawsuit, Did Your Membership Renew Without Proper Notice?

You do not qualify if you are a Pharmacy Benefit Manager (PBM), a government entity (other than cities, towns, or municipalities with self-funded drug plans), or a personal injury claimant in this MDL. You also do not qualify if you paid nothing out of pocket because your insurer covered the full cost.

How Much Money Can You Receive?

Your payment amount depends on how many 30-day supplies of qualifying Vivimed Losartan you purchased and whether you can document what you paid.

Standard payment — no documentation required: The settlement pays $4.30 for each 30-day supply you purchased, up to a maximum of $43 (ten 30-day supplies). You do not need to submit receipts for this tier. The settlement administrator may still ask you to verify your claim, so it helps to have your pharmacy records ready even if you do not submit them upfront.

Enhanced payment — documentation required: If you paid more than $4.30 per 30-day supply out of pocket, you can claim a higher amount with no per-supply or total cap on the enhanced tier. You must submit pharmacy receipts or records that show what you actually paid. There is, however, an overall cap: total payments to consumers cannot exceed 90% of the net settlement fund after attorneys’ fees, administration costs, and service awards are deducted. If total valid claims exceed that cap, the settlement administrator will reduce all payments proportionally.

Practical note for most patients: If you picked up your Losartan at a retail pharmacy using insurance and paid only a copay, your reimbursable amount is your actual out-of-pocket copay — not the full prescription price. If you paid cash with no insurance, your documented cost is the full retail price per fill.

How to File Your Claim Before June 2, 2026

Step 1 — Go to the official claim portal at sartanmedicationsettlement.pnclassaction.com. This is the only authorized online claim site for this settlement.

Step 2 — Enter your personal information, including your name, address, and contact details.

Step 3 — Identify the Vivimed Losartan you purchased by entering the qualifying NDC code and the number of 30-day supplies you purchased.

Step 4 — If you are claiming more than $4.30 per 30-day supply, upload supporting documentation such as pharmacy receipts, insurance explanation-of-benefits statements showing your out-of-pocket costs, or pharmacy dispensing records.

Step 5 — Review and submit your claim form.

Step 6 — Save your confirmation number for your records.

Prefer to file by mail? Download the PDF claim form at sartanmedicationsettlement.com, complete it, and mail it postmarked no later than June 2, 2026 to:

Vivimed Settlement Notice Administrator PO Box 3376 Baton Rouge, LA 70821

Questions? Call toll-free (1-866-875-9644) or email [email protected].

Estimated time to complete: 5–10 minutes online for standard claims; 15–20 minutes if uploading documentation.

Key Dates to Know

Milestone	Date
Vivimed Losartan Recall Announced	May 3, 2019
MDL Filed in District of New Jersey	2019
Settlement Preliminary Approval	TBD (per court docket)
Claims Period Opens	Now open
Claim Filing Deadline	June 2, 2026
Opt-Out Deadline	June 2, 2026
Objection Deadline	June 2, 2026
Final Approval Hearing	June 30, 2026 at 10:00 a.m. ET
Expected Payment Date	After final approval and resolution of any appeals

Frequently Asked Questions

Do I need a lawyer to file a claim? 

No. Court-appointed class counsel — including attorneys from Slack Davis Sanger LLP, Honik Law, and Kanner & Whiteley LLC — represent all settlement class members at no charge. Filing a claim yourself is free and straightforward. You only need to hire your own attorney if you want individual representation, which is entirely optional.

Is this settlement legitimate?

 Yes. The U.S. District Court for the District of New Jersey authorized and oversees this settlement as part of In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation, Case No. 1:19-md-02875-RBK-SAK. Postlethwaite & Netterville, the court-appointed settlement administrator, manages claims through the only official site: sartanmedicationsettlement.com.

When will I receive my payment? 

The court holds its final approval hearing on June 30, 2026. If the judge approves the settlement and no appeals follow, payments go out after that point. The exact timeline depends on how quickly the court resolves any post-hearing appeals and how long claims processing takes — typically several months after final approval.

What if I missed the claim deadline?

 The claim deadline is June 2, 2026. If you do not file by that date, you will receive no payment from this settlement. You will also give up your right to sue Vivimed separately for economic losses related to this contamination. File as early as possible — do not wait until the last day.

Will this settlement payment affect my taxes? 

Possibly. Cash payments from product contamination settlements may count as taxable income depending on how the IRS characterizes the payment — whether it compensates for a financial loss or constitutes income. Consult a tax professional about your specific circumstances before filing your return.

I don’t have my old pill bottle — can I still file? 

Yes. Your pharmacy keeps dispensing records going back several years. Contact your pharmacy and ask for a printout of your prescription history, which will show the manufacturer, NDC code, and what you paid. This record is typically available at no cost and can substitute for a pill bottle label.

Does this settlement cover my health problems from taking contaminated Losartan?

 No. This settlement covers only economic losses — meaning what you paid for the medication. It does not compensate for any personal injuries, health conditions, or cancer risks you may associate with the contamination. If you believe you suffered physical harm from NMBA-contaminated Losartan, consult a personal injury attorney about your options, as those claims are separate from this economic loss settlement.

Is this the same as the Valsartan or Irbesartan settlements? 

No, but they are part of the same MDL. The Vivimed Losartan settlement ($1,899,000) covers only the eight specific Vivimed NDC codes listed above. Separate settlements exist for Hetero Valsartan ($11,365,489.80) and Aurobindo Irbesartan ($2,000,000) — each with their own qualifying products and NDC codes. All three share the same claim deadline of June 2, 2026 and the same settlement administrator.

If you are researching other active product-related class action settlements with June 2026 deadlines, our coverage of the CAMC data breach settlement and how to claim up to $6,080 explains a similarly structured compensation process. For a broader look at how contaminated product recalls lead to consumer class actions, the Balance of Nature lawsuit update covers how FDA-regulated product cases move through the courts.

Sources & References

1. Official MDL Settlement Website — sartanmedicationsettlement.com
2. Vivimed-Losartan Long-Form Class Notice (Postlethwaite & Netterville) — sartanmedicationsettlement.com/court-documents
3. Court PR Newswire Notice (April 2, 2026) — In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation, Case No. 1:19-md-02875-RBK-SAK

Last Updated: April 7, 2026

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Legal claims and outcomes depend on specific facts and applicable law. For advice regarding a particular situation, consult a qualified attorney.